ÌìÃÀÓ°Ôº

A clinical-stage biotech focused on neurology faced challenges with a lipophilic, oxidation-sensitive molecule limited by solubility, stability, and scalability.

Vinorelbine, a chemotherapy agent traditionally given by IV infusion, was reformulated into the first approved oral softgel capsule through a collaboration between Pierre Fabre and ÌìÃÀÓ°Ôº.

Bringing complex oral drugs to the clinic requires overcoming significant solubility, permeability, and bioavailability challenges.

Summary: Pharmaceutical innovators face growing pressure to overcome solubility, permeability, and bioavailability challenges, especially for complex, poorly soluble molecules.

Softgels are a versatile and scalable platform for pharmaceutical development with the ability to improve bioavailability, enhance patient compliance, and accommodate diverse formulations.

Learn how our proprietary expertise and proven techniques provide stable, integrated softgel solutions that achieve development goals.

Join our expert-led panel to explore innovative formulation strategies, the diverse mechanisms of action, preclinical and clinical considerations, as well as encapsulation techniques, and more.

Summary: Softgels are ideal for LBF delivery and are compatible with various formulations. Innovations like delayed release and plant-based capsules enhance drug delivery. LBFs with a Quality-by-Design approach offer an efficient route to market for complex drugs.

Learn how softgel capsules have advanced drug delivery by encapsulating a variety of active pharmaceutical ingredients (APIs).

Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.